23
Mar 2021 10:00 - 12:30

Future development and current challenges of mHealth apps and Digital Therapeutics

Format Online
Language ENGLISH
Location Diretta Streaming

The unparalleled surge in digital health adoption during the COVID-19 pandemic has emphasized the potential of mHealth apps and digital therapeutics to prevent, to predict and to treat infectious as well as chronic conditions. 

Regulatory bodies are expected to develop their current approaches adopting comprehensive evaluation processes that adequately consider mHealth apps and digital therapeutics' specific features. 

The key findings from a review of the regulatory aspects of mobile health apps and digital therapeutics in the different international contexts will be presented and discussed with international experts from the European Commission, Food & Drug Administration, Italian Public Health Institute (ISS), HTA Agencies and Industry.



All event materials are now available

Download

Related Articles

Internal auditing in healthcare: current and future status
Authors
Required time 5 min
Biogen: managing healthcare challenges between complexit...
Authors
Required time 6 min
Value-Based Management in healthcare
Required time 8 min